H6: 2017 failure to follow steps/instructions a visual and dimensional inspection was performed on the returned device.The reported stent dislodgement was confirmed.The reported difficult to remove could not be tested based on the condition of the returned device.It should be noted that the xience xpedition, everolimus eluting coronary stent system, instructions for use (ifu) states: prior to using the xience xpedition, everolimus eluting coronary stent system, carefully remove the system from the package and inspect for bends, kinks, and other damage.Verify that the stent does not extend beyond the radiopaque balloon markers.Do not use if any defects are noted.The ifu deviation does not appear to have directly caused or contributed to the reported difficulties.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.H6: patient code 2645 was removed.
|